Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1997 Apr;105(Suppl 3):587–592. doi: 10.1289/ehp.97105s3587

Endogenous estrogens and breast cancer risk: the case for prospective cohort studies.

P G Toniolo 1
PMCID: PMC1469902  PMID: 9168000

Abstract

It is generally agreed that estrogens, and possibly androgens, are important in the etiology of breast cancer, but no consensus exists as to the precise estrogenic or androgenic environment that characterizes risk, or the exogenous factors that influence the hormonal milieu. Nearly all the epidemiological studies conducted in the 1970s and 1980s were hospital-based case-control studies in which specimen sampling was performed well after the clinical appearance of the disease. Early prospective cohort studies also had limitations in their small sample sizes or short follow-up periods. However, more recent case-control studies nested within large cohorts, such as the New York University Women's Health Study and the Ormoni e Dieta nell'Eziologia dei Tumori study in Italy, are generating new data indicating that increased levels of estrone, estradiol and bioavailable estradiol, as well as their androgenic precursors, may be associated with a 4- to 6-fold increase in the risk of postmenopausal breast cancer. Further new evidence, which complements and expands the observations from the latter studies, shows that women with the thickest bone density, which may be a surrogate for cumulated exposure to hormones, experience severalfold increased risk of subsequent breast cancer as compared to women with thin bones. These data suggests that endogenous sex hormones are a key factor in the etiology of postmenopausal breast cancer. New prospective cohort studies should be conducted to examine the role of endogenous sex hormones in blood and urine samples obtained early in the natural history of breast cancer jointly with an assessment of bone density and of other important risk factors, such as mammographic density, physical activity, body weight, and markers of individual susceptibility, which may confer increased risk through an effect on the metabolism of endogenous hormones or through specific metabolic responses to Western lifestyle and diet.

Full text

PDF
587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H. O., Johansson E. D., Vegelius J., Victor A. Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups J Med Sci. 1979;84(3):259–274. doi: 10.3109/03009737909179163. [DOI] [PubMed] [Google Scholar]
  2. Adlercreutz H., Hämäläinen E., Gorbach S. L., Goldin B. R., Woods M. N., Dwyer J. T. Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr. 1989 Mar;49(3):433–442. doi: 10.1093/ajcn/49.3.433. [DOI] [PubMed] [Google Scholar]
  3. Albanes D., Taylor P. R. International differences in body height and weight and their relationship to cancer incidence. Nutr Cancer. 1990;14(1):69–77. doi: 10.1080/01635589009514078. [DOI] [PubMed] [Google Scholar]
  4. Bernstein L., Ross R. K., Pike M. C., Brown J. B., Henderson B. E. Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br J Cancer. 1990 Feb;61(2):298–302. doi: 10.1038/bjc.1990.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berrino F., Muti P., Micheli A., Bolelli G., Krogh V., Sciajno R., Pisani P., Panico S., Secreto G. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst. 1996 Mar 6;88(5):291–296. doi: 10.1093/jnci/88.5.291. [DOI] [PubMed] [Google Scholar]
  6. Bruning P. F., Bonfrèr J. M., Hart A. A. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk. Br J Cancer. 1985 Apr;51(4):479–484. doi: 10.1038/bjc.1985.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bruning P. F., Bonfrèr J. M., Hart A. A., van Noord P. A., van der Hoeven H., Collette H. J., Battermann J. J., de Jong-Bakker M., Nooijen W. J., de Waard F. Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer. 1992 Apr 22;51(1):14–19. doi: 10.1002/ijc.2910510104. [DOI] [PubMed] [Google Scholar]
  8. Bulbrook R. D., Moore J. W., Clark G. M., Wang D. Y., Millis R. R., Hayward J. L. Relation between risk of breast cancer and biological availability of estradiol in the blood: prospective study in Guernsey. Ann N Y Acad Sci. 1986;464:378–388. doi: 10.1111/j.1749-6632.1986.tb16017.x. [DOI] [PubMed] [Google Scholar]
  9. Cauley J. A., Lucas F. L., Kuller L. H., Vogt M. T., Browner W. S., Cummings S. R. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA. 1996 Nov 6;276(17):1404–1408. [PubMed] [Google Scholar]
  10. Cole P., Cramer D., Yen S., Paffenbarger R., MacMahon B., Brown J. Estrogen profiles of premenopausal women with breast cancer. Cancer Res. 1978 Mar;38(3):745–748. [PubMed] [Google Scholar]
  11. Cole P., MacMahon B. Oestrogen fractions during early reproductive life in the aetiology of breast cancer. Lancet. 1969 Mar 22;1(7595):604–606. doi: 10.1016/s0140-6736(69)91537-2. [DOI] [PubMed] [Google Scholar]
  12. Dickson R. B., Lippman M. E. Control of human breast cancer by estrogen, growth factors, and oncogenes. Cancer Treat Res. 1988;40:119–165. doi: 10.1007/978-1-4613-1733-3_6. [DOI] [PubMed] [Google Scholar]
  13. Dorgan J. F., Longcope C., Stephenson H. E., Jr, Falk R. T., Miller R., Franz C., Kahle L., Campbell W. S., Tangrea J. A., Schatzkin A. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1996 Jul;5(7):533–539. [PubMed] [Google Scholar]
  14. England P. C., Skinner L. G., Cottrell K. M., Sellwood R. A. Serum oestradiol-17 beta in women with benign and malignant breast disease. Br J Cancer. 1974 Dec;30(6):571–576. doi: 10.1038/bjc.1974.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Garland C. F., Friedlander N. J., Barrett-Connor E., Khaw K. T. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol. 1992 Jun 1;135(11):1220–1230. doi: 10.1093/oxfordjournals.aje.a116228. [DOI] [PubMed] [Google Scholar]
  16. Grattarola R., Secreto G., Recchione C., Castellini W. Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. Am J Obstet Gynecol. 1974 Jan 15;118(2):173–178. [PubMed] [Google Scholar]
  17. Helzlsouer K. J., Alberg A. J., Bush T. L., Longcope C., Gordon G. B., Comstock G. W. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev. 1994;18(2):79–85. [PubMed] [Google Scholar]
  18. Helzlsouer K. J., Comstock G. W., Morris J. S. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res. 1989 Nov 1;49(21):6144–6148. [PubMed] [Google Scholar]
  19. Hunter D. J., Willett W. C. Diet, body size, and breast cancer. Epidemiol Rev. 1993;15(1):110–132. doi: 10.1093/oxfordjournals.epirev.a036096. [DOI] [PubMed] [Google Scholar]
  20. Jones L. A., Ota D. M., Jackson G. A., Jackson P. M., Kemp K., Anderson D. E., McCamant S. K., Bauman D. H. Bioavailability of estradiol as a marker for breast cancer risk assessment. Cancer Res. 1987 Oct 1;47(19):5224–5229. [PubMed] [Google Scholar]
  21. Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control. 1996 Nov;7(6):605–625. doi: 10.1007/BF00051703. [DOI] [PubMed] [Google Scholar]
  22. Kato I., Tominaga S., Kuroishi T. Relationship between westernization of dietary habits and mortality from breast and ovarian cancers in Japan. Jpn J Cancer Res. 1987 Apr;78(4):349–357. [PubMed] [Google Scholar]
  23. Kelsey J. L., Gammon M. D. Epidemiology of breast cancer. Epidemiol Rev. 1990;12:228–240. doi: 10.1093/oxfordjournals.epirev.a036056. [DOI] [PubMed] [Google Scholar]
  24. Kelsey J. L., Gammon M. D., John E. M. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36–47. doi: 10.1093/oxfordjournals.epirev.a036115. [DOI] [PubMed] [Google Scholar]
  25. Key T. J., Pike M. C. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988 Jan;24(1):29–43. doi: 10.1016/0277-5379(88)90173-3. [DOI] [PubMed] [Google Scholar]
  26. Key T. J., Wang D. Y., Brown J. B., Hermon C., Allen D. S., Moore J. W., Bulbrook R. D., Fentiman I. S., Pike M. C. A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer. 1996 Jun;73(12):1615–1619. doi: 10.1038/bjc.1996.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kuller L. H., Gutai J. P. Re: "Sex hormone levels in serum in relation to the development of breast cancer". Am J Epidemiol. 1988 Jan;127(1):201–202. doi: 10.1093/oxfordjournals.aje.a114784. [DOI] [PubMed] [Google Scholar]
  28. LILIENFELD A. M. The relationship of cancer of the female breast to artificial menopause and martial status. Cancer. 1956 Sep-Oct;9(5):927–934. doi: 10.1002/1097-0142(195609/10)9:5<927::aid-cncr2820090510>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  29. Langley M. S., Hammond G. L., Bardsley A., Sellwood R. A., Anderson D. C. Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases. J Natl Cancer Inst. 1985 Nov;75(5):823–829. doi: 10.1093/jnci/75.5.823. [DOI] [PubMed] [Google Scholar]
  30. MACKENZIE I. The production of mammary cancer in rats using oestrogens. Br J Cancer. 1955 Jun;9(2):284–299. doi: 10.1038/bjc.1955.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. MARMORSTON J., CROWLEY L. G., MYERS S. M., STERN E., HOPKINS C. E. II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE. Am J Obstet Gynecol. 1965 Jun 15;92:460–467. doi: 10.1016/s0002-9378(16)34835-9. [DOI] [PubMed] [Google Scholar]
  32. MacMahon B., Cole P., Brown J. B., Aoki K., Lin T. M., Morgan R. W., Woo N. C. Urine oestrogen profiles of Asian and North American women. Int J Cancer. 1974 Aug 15;14(2):161–167. doi: 10.1002/ijc.2910140204. [DOI] [PubMed] [Google Scholar]
  33. MacMahon B., Cole P., Brown J. B., Paffenbarger R., Trichopoulos D., Yen S. Urine estrogens, frequency of ovulation, and breast cancer risk: case-control study in premenopausal women. J Natl Cancer Inst. 1983 Feb;70(2):247–250. [PubMed] [Google Scholar]
  34. MacMahon B., Trichopoulos D., Brown J., Andersen A. P., Cole P., deWaard F., Kauraniemi T., Polychronopoulou A., Ravnihar B., Stormby N. Age at menarche, urine estrogens and breast cancer risk. Int J Cancer. 1982 Oct 15;30(4):427–431. doi: 10.1002/ijc.2910300408. [DOI] [PubMed] [Google Scholar]
  35. Malarkey W. B., Schroeder L. L., Stevens V. C., James A. G., Lanese R. R. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res. 1977 Dec;37(12):4655–4659. [PubMed] [Google Scholar]
  36. McFadyen I. J., Forrest A. P., Prescott R. J., Golder M. P., Groom G. V., Fahmy D. R., Griffiths K. Circulating hormone concentrations in women with breast cancer. Lancet. 1976 May 22;1(7969):1100–1102. doi: 10.1016/s0140-6736(76)90064-7. [DOI] [PubMed] [Google Scholar]
  37. Mendel C. M. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev. 1989 Aug;10(3):232–274. doi: 10.1210/edrv-10-3-232. [DOI] [PubMed] [Google Scholar]
  38. Meyer F., Brown J. B., Morrison A. S., MacMahon B. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst. 1986 Sep;77(3):613–616. doi: 10.1093/jnci/77.3.613. [DOI] [PubMed] [Google Scholar]
  39. Moore J. W., Clark G. M., Bulbrook R. D., Hayward J. L., Murai J. T., Hammond G. L., Siiteri P. K. Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int J Cancer. 1982 Jan 15;29(1):17–21. doi: 10.1002/ijc.2910290105. [DOI] [PubMed] [Google Scholar]
  40. Moore J. W., Clark G. M., Hoare S. A., Millis R. R., Hayward J. L., Quinlan M. K., Wang D. Y., Bulbrook R. D. Binding of oestradiol to blood proteins and aetiology of breast cancer. Int J Cancer. 1986 Nov 15;38(5):625–630. doi: 10.1002/ijc.2910380502. [DOI] [PubMed] [Google Scholar]
  41. Morreal C. E., Dao T. L., Nemoto T., Lonergan P. A. Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer. J Natl Cancer Inst. 1979 Nov;63(5):1171–1174. [PubMed] [Google Scholar]
  42. Olsson H., Hägglund G. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. Am J Epidemiol. 1992 Aug 15;136(4):422–427. doi: 10.1093/oxfordjournals.aje.a116515. [DOI] [PubMed] [Google Scholar]
  43. Ota D. M., Jones L. A., Jackson G. L., Jackson P. M., Kemp K., Bauman D. Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients. Cancer. 1986 Feb 1;57(3):558–562. doi: 10.1002/1097-0142(19860201)57:3<558::aid-cncr2820570326>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  44. Persson I., Adami H. O., McLaughlin J. K., Naessén T., Fraumeni J. F., Jr Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden). Cancer Causes Control. 1994 Nov;5(6):523–528. doi: 10.1007/BF01831380. [DOI] [PubMed] [Google Scholar]
  45. Persson I., Naessén T., Adami H. O., Bergström R., Lagrelius A., Möllerström G., Pettersson B., von Hamos K. Reduced risk of hip fracture in women with endometrial cancer. Int J Epidemiol. 1992 Aug;21(4):636–642. doi: 10.1093/ije/21.4.636. [DOI] [PubMed] [Google Scholar]
  46. Pike M. C., Spicer D. V., Dahmoush L., Press M. F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15(1):17–35. doi: 10.1093/oxfordjournals.epirev.a036102. [DOI] [PubMed] [Google Scholar]
  47. Prentice R. L. On the design of synthetic case-control studies. Biometrics. 1986 Jun;42(2):301–310. [PubMed] [Google Scholar]
  48. Reed M. J., Beranek P. A., Cheng R. W., Ghilchik M. W., James V. H. The distribution of oestradiol in plasma from postmenopausal women with or without breast cancer: relationships with metabolic clearance rates of oestradiol. Int J Cancer. 1985 Apr 15;35(4):457–460. doi: 10.1002/ijc.2910350407. [DOI] [PubMed] [Google Scholar]
  49. Reed M. J., Cheng R. W., Noel C. T., Dudley H. A., James V. H. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. Cancer Res. 1983 Aug;43(8):3940–3943. [PubMed] [Google Scholar]
  50. Robins J. M., Gail M. H., Lubin J. H. More on "Biased selection of controls for case-control analyses of cohort studies". Biometrics. 1986 Jun;42(2):293–299. [PubMed] [Google Scholar]
  51. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev. 1990 Feb;11(1):80–91. doi: 10.1210/edrv-11-1-80. [DOI] [PubMed] [Google Scholar]
  52. Secreto G., Toniolo P., Pisani P., Recchione C., Cavalleri A., Fariselli G., Totis A., Di Pietro S., Berrino F. Androgens and breast cancer in premenopausal women. Cancer Res. 1989 Jan 15;49(2):471–476. [PubMed] [Google Scholar]
  53. Siiteri P. K., Simberg N., Murai J. Estrogens and breast cancer. Ann N Y Acad Sci. 1986;464:100–105. doi: 10.1111/j.1749-6632.1986.tb15997.x. [DOI] [PubMed] [Google Scholar]
  54. Siiteri P. K., Simberg N., Murai J. Estrogens and breast cancer. Ann N Y Acad Sci. 1986;464:100–105. doi: 10.1111/j.1749-6632.1986.tb15997.x. [DOI] [PubMed] [Google Scholar]
  55. Takatani O., Kosano H., Okumoto T., Akamatsu K., Tamakuma S., Hiraide H. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls. J Natl Cancer Inst. 1987 Dec;79(6):1199–1204. [PubMed] [Google Scholar]
  56. Teruel M., Bolufer P., Rodriguez A., Antonio P., Salabert M. T. Plasma sex steroids and SHBG in patients with breast cancer and their relation to tumor oestrogen-dependency. Exp Clin Endocrinol. 1989 Apr;93(1):37–44. doi: 10.1055/s-0029-1210834. [DOI] [PubMed] [Google Scholar]
  57. Thijssen J. H., Poortman J., Schwarz F. Androgens in postmenopausal breast cancer: excretion, production and interaction with estrogens. J Steroid Biochem. 1975 May;6(5):729–734. doi: 10.1016/0022-4731(75)90060-6. [DOI] [PubMed] [Google Scholar]
  58. Toniolo P. G., Levitz M., Zeleniuch-Jacquotte A., Banerjee S., Koenig K. L., Shore R. E., Strax P., Pasternack B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995 Feb 1;87(3):190–197. doi: 10.1093/jnci/87.3.190. [DOI] [PubMed] [Google Scholar]
  59. Toniolo P. G., Pasternack B. S., Shore R. E., Sonnenschein E., Koenig K. L., Rosenberg C., Strax P., Strax S. Endogenous hormones and breast cancer: a prospective cohort study. Breast Cancer Res Treat. 1991 May;18 (Suppl 1):S23–S26. doi: 10.1007/BF02633522. [DOI] [PubMed] [Google Scholar]
  60. Trichopoulos D., Yen S., Brown J., Cole P., MacMahon B. The effect of westernization on urine estrogens, frequency of ovulation, and breast cancer risk. A study of ethnic Chinese women in the Orient and the USA. Cancer. 1984 Jan 1;53(1):187–192. doi: 10.1002/1097-0142(19840101)53:1<187::aid-cncr2820530133>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  61. Vermeulen A. Human mammary cancer as a site of sex steroid metabolism. Cancer Surv. 1986;5(3):585–595. [PubMed] [Google Scholar]
  62. Wynder E. L., Hebert J. R. Homogeneity in nutritional exposure: an impediment in cancer epidemiology. J Natl Cancer Inst. 1987 Sep;79(3):605–607. [PubMed] [Google Scholar]
  63. Wysowski D. K., Comstock G. W., Helsing K. J., Lau H. L. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol. 1987 May;125(5):791–799. doi: 10.1093/oxfordjournals.aje.a114596. [DOI] [PubMed] [Google Scholar]
  64. Zaridze D., Kushlinskii N., Moore J. W., Lifanova Y. e., Bassalyk L., Wang D. Y. Endogenous plasma sex hormones in pre- and postmenopausal women with breast cancer: results from a case-control study in Moscow. Eur J Cancer Prev. 1992 Apr;1(3):225–230. doi: 10.1097/00008469-199204000-00003. [DOI] [PubMed] [Google Scholar]
  65. Ziegler R. G., Hoover R. N., Pike M. C., Hildesheim A., Nomura A. M., West D. W., Wu-Williams A. H., Kolonel L. N., Horn-Ross P. L., Rosenthal J. F. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993 Nov 17;85(22):1819–1827. doi: 10.1093/jnci/85.22.1819. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES